Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 3, 1999, Pages 689-696

  Tilton, Ronald G ^a   Chang, Katherine C ^b   Lejeune, Wanda S ^a   Stephan, Clifford C ^a   Brock, Tommy A ^a   Williamson, Joseph R ^b  

^a TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART FUNCTION; HEART OUTPUT; HEMODYNAMIC MONITORING; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ANIMALS; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EYE; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; LYMPHOKINES; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033018643     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ferrara N, Houck L, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
2. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to platelet derived growth factor Science. 1989;246:1309-1312.
3. Ratajska A, Torry RJ, Kitten GT, Kolker SJ, Tomanek RJ. Modulation of cell migration and vessel formation by vascular endothelial growth factor and basic fibroblast growth factor in cultured embryonic heart. Dev Dyn. 1995;203:399-407.
4. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029-1039.
5. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dcpendent relaxation in coronary arteries. Am J Physiol. 1993;265:H586-H592.
6. Wu HM, Huang Q, Yuan Y, Granger HJ. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol. 1996; 271:H2735-H2739.
7. Lopez JJ, Laham RJ, Carrozza JP, et al. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response Am J Physiol. 1997;273:H1317-H1323.
8. Yang R, Thomas GR, Bunting S, et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol. 1996;27:838-844.
9. Tilton RG, Kawamura T, Chang KC, et al. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest. 1997;99:2192-2202.
10. Hood JD, Meininger CJ, Ziehe M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol. 1998;274:H1054-H1058.
11. Murohara T, Horowitz JR, Silver M, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998;97: 99-107.
12. Collins P, Connolly D, Williams T. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol. 1993;109:195-199.
13. Aiello LP, Bursell S-E, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β isoformselective inhibitor. Diabetes. 1997;46:1473-1480.
14. Banai S, Jaklitsch M, Shou M, et al. Angiogenic-induccd enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
15. Bauters C, Asahara T, Zheng LP, et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation. 1995;91:2802-2809.
16. Asahara T, Bauters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793-2801.
17. Fiebich BL, Jäger B, Schöllmann C, et al. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur J Biochem. 1993;211:19-26.
18. Pugliese G, Tilton RG, Speedy A, et al. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity. Metabolism. 1990;39:690-697.
19. Tilton RG, Chang KC, Hasan KS, et al. Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation endproduct formation. Diabetes. 1993;42:221-232.
20. Tilton RG, Chang KC, Corbett JA, et al. Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci. 1994;35:3278-3288.
21. Tilton RG, Chang KC, Nyengaard JR, Van den Enden M, Ido Y, Williamson JR. Inhibition of sorbitol dehydrogenase: effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats. Diabetes. 1995;44:234-242.
22. G-nitro-L-arginine. Am J Physiol. 1992;262:F939-F942.
23. Granstam SO, Lind L, Granstam E, et al. Effects of nitric oxide synthase inhibition and endothelin ETA receptor blockade on haemodynamics in hypertensive rats. Clin Exp Pharmacol Physiol. 1998;25:693-701.
24. Fujii E, Irie K, Ohba K, et al. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin. Naunyn Schmiedebergs Arch Pharmacol. 1997;35:475-480.
25. Horowitz JR, Rivard A, van der Zee R, et al. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterioscler Tbromb Vasc Biol. 1997; 17:2793-2800.
26. Laitinen M, Zachary I, Breier G, et al. VEGF gene transfer reduces intimai thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther. 1997;8:1737-1744.
27. DeVries C, Escobedo J, Ueno H, Houck K, Ferrara N, Williams L. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992;255:989-991.
28. Peters K, deVries C, Williams L. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA. 1993;90:8915-8919.
29. Jakeman L, WinerJ, Bennett G, Altar C, Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest. 1992;89:244-253.
30. Gilbert RE, Vranes D, Berka JL, et al. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest. 1998;78:1017-1027.
31. Monacci W, Merrill M, Oldfield E. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol. 1993;264:C995-C1002.
32. Wen Y, Edelman JL, Kang T, Zeng N, Sachs G. Two functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retina. J Biol Chem. 1998;273:2090-2097.
33. Takagi H, King GL, Aiello LP. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes. 1996;45:1016-1023.
34. Xia P, Aiello LP, Ishii H, et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest. 1996;98: 2018-2026.
35. Ramirez MM, Kim DD, Duran WN. Protein kinase C modulates microvascular permeability through nitric oxide synthase. Am J Pbysiol. 1996;271:H1702-H1705.
36. Huang Q, Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol 1997;273: H2442-H2451.
37. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995;108:2369-2379.
38. Roberts WG, GE Palade. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 1997;57:765-772.
39. Kilzer P, Chang K, Marvel J, Kilo C, Williamson JR. Tissue differences in vascular permeability changes induced by histamine. Microvasc Res. 1985;30:270-285.
40. 2 in the rat. Prostaglandins. 1986;32:5-17.
41. Williamson JR, Holmberg S, Chang K, Marvel J, Sutera SP, Needleman P. Mechanisms underlying atriopeptin-induced increases in hematocrit and vascular permeation in rats. Circ Res. 1989;64: 890-899.
42. Worrall NK, Chang K, LeJuene WS, et al. TNF-α causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. Am J Physiol. 1997;42:H2565-H2574.
43. Criscuolo G, Merrill M, Oldfield E. Characterization of a protein product of human malignant glial tumors that induces microvascular permeability. Adv Neurol. 1990;52:469-474.
44. Wang W, Merrill M, Borchardt R. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am J Physiol. 1996;271:C1973-C1980.